MYD88 (L265P) mutation is an independent prognostic factor for outcome in patients with diffuse large B-cell lymphoma

被引：52

作者：

Fernandez-Rodriguez, C. ^{[1
,2
]}

Bellosillo, B. ^{[1
,3
,4
]}

Garcia-Garcia, M. ^{[3
]}

Sanchez-Gonzalez, B. ^{[1
,5
]}

Gimeno, E. ^{[1
,5
]}

Vela, M. C. ^{[3
]}

Serrano, S. ^{[3
]}

Besses, C. ^{[1
,5
]}

Salar, A. ^{[1
,5
]}

机构：

[1] Hosp Mar IMIM, Grp Recerca Clin Aplicada Neoplasies Hematol, Barcelona, Spain

[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain

[3] Hosp Mar IMIM, Dept Pathol, Barcelona, Spain

[4] Univ Pompeu Fabra, Barcelona, Spain

[5] Hosp Mar IMIM, Dept Hematol, Barcelona, Spain

来源：

LEUKEMIA | 2014年 / 28卷 / 10期

关键词：

EXPRESSION;

D O I：

10.1038/leu.2014.184

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2104 / 2106

页数：4

共 15 条

[1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[2] MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type [J].

Anne Pham-Ledard ;

Cappellen, David ;

Martinez, Fabian ;

Vergier, Beatrice ;

Beylot-Barry, Marie ;

Merlio, Jean-Philippe .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (08) :2118-2120

[3]

[Anonymous], BLOOD

[4] Targetable Activating Mutations are Very Frequent in GCB and ABC Diffuse Large B-Cell Lymphoma [J].

Bohers, Elodie ;

Mareschal, Sylvain ;

Bouzelfen, Abdelilah ;

Marchand, Vinciane ;

Ruminy, Philippe ;

Maingonnat, Catherine ;

Menard, Anne-Lise ;

Etancelin, Pascaline ;

Bertrand, Philippe ;

Dubois, Sydney ;

Alcantara, Marion ;

Bastard, Christian ;

Tilly, Herve ;

Jardin, Fabrice .

GENES CHROMOSOMES & CANCER, 2014, 53 (02) :144-153

[5] MYD88 expression and L265P mutation in diffuse large B-cell lymphoma [J].

Choi, Jung-Woo ;

Kim, Younghye ;

Lee, Ju-Han ;

Kim, Young-Sik .

HUMAN PATHOLOGY, 2013, 44 (07) :1375-1381

[6] Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas [J].

Gonzalez-Aguilar, Alberto ;

Idbaih, Ahmed ;

Boisselier, Blandine ;

Habbita, Naima ;

Rossetto, Marta ;

Laurenge, Alice ;

Bruno, Aurelie ;

Jouvet, Anne ;

Polivka, Marc ;

Adam, Clovis ;

Figarella-Branger, Dominique ;

Miquel, Catherine ;

Vital, Anne ;

Ghesquieres, Herve ;

Gressin, Remy ;

Delwail, Vincent ;

Taillandier, Luc ;

Chinot, Olivier ;

Soubeyran, Pierre ;

Gyan, Emmanuel ;

Choquet, Sylvain ;

Houillier, Caroline ;

Soussain, Carole ;

Tanguy, Marie-Laure ;

Marie, Yannick ;

Mokhtari, Karima ;

Hoang-Xuan, Khe .

CLINICAL CANCER RESEARCH, 2012, 18 (19) :5203-5211

[7] Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].

Hans, CP ;

Weisenburger, DD ;

Greiner, TC ;

Gascoyne, RD ;

Delabie, J ;

Ott, G ;

Müller-Hermelink, HK ;

Campo, E ;

Braziel, RM ;

Jaffe, ES ;

Pan, ZG ;

Farinha, P ;

Smith, LM ;

Falini, B ;

Banham, AH ;

Rosenwald, A ;

Staudt, LM ;

Connors, JM ;

Armitage, JO ;

Chan, WC .

BLOOD, 2004, 103 (01) :275-282

[8] MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia [J].

Jimenez, C. ;

Sebastian, E. ;

Chillon, M. C. ;

Giraldo, P. ;

Hernandez, J. Mariano ;

Escalante, F. ;

Gonzalez-Lopez, T. J. ;

Aguilera, C. ;

de Coca, A. G. ;

Murillo, I. ;

Alcoceba, M. ;

Balanzategui, A. ;

Sarasquete, M. E. ;

Corral, R. ;

Marin, L. A. ;

Paiva, B. ;

Ocio, E. M. ;

Gutierrez, N. C. ;

Gonzalez, M. ;

Miguel, J. F. San ;

Garcia-Sanz, R. .

LEUKEMIA, 2013, 27 (08) :1722-1728

[9] High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma [J].

Kraan, W. ;

van Keimpema, M. ;

Horlings, H. M. ;

Schilder-Tol, E. J. M. ;

Oud, M. E. C. M. ;

Noorduyn, L. A. ;

Kluin, P. M. ;

Kersten, M. J. ;

Spaargaren, M. ;

Pals, S. T. .

LEUKEMIA, 2014, 28 (03) :719-720

[10] High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites [J].

Kraan, W. ;

Horlings, H. M. ;

van Keimpema, M. ;

Schilder-Tol, E. J. M. ;

Oud, M. E. C. M. ;

Scheepstra, C. ;

Kluin, P. M. ;

Kersten, M. J. ;

Spaargaren, M. ;

Pals, S. T. .

BLOOD CANCER JOURNAL, 2013, 3 :e139-e139

← 1 2 →